Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter studyNiccolò Gori, Ketty Peris, Marco Galluzzo et al.|Journal of Dermatological Treatment|2023Cited by 12
<i>Letter:</i> Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting—IL ADGiuseppe Lauletta, Maddalena Napolitano, Luca Potestio et al.|Dermatitis|2025Cited by 4